Literature DB >> 10873068

High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas.

H J Aronen1, F S Pardo, D N Kennedy, J W Belliveau, S D Packard, D W Hsu, F H Hochberg, A J Fischman, B R Rosen.   

Abstract

The purpose of this investigation was to elucidate the association between microvascular blood volume and glucose uptake and to link these measures with tumor angiogenesis. We demonstrate a regionally specific correlation between tumor relative microvascular blood volume (CBV), determined in vivo with functional magnetic resonance imaging techniques, and tumor glucose uptake determined with fluorodeoxyglucose positron emission tomography. Regions of maximum glucose uptake were well matched with maximum CBV across all patients (n = 21; r = 0.572; P = 0.023). High-grade gliomas showed significantly elevated CBV and glucose uptake compared with low-grade gliomas, (P = 0.009 and 0.008, respectively). Correlations between CBV and glucose uptake were then determined on a voxel-by-voxel basis within each patient's glioma. Correlation indices varied widely, but in 16 of 21 cases of human glioma, CBV and glucose uptake were correlated (r > 0.150). These measures were well correlated in all cases when comparing healthy brain tissue in these same patients. Tumor vascularity, as determined immunohistochemically and morphometrically on clinical samples, revealed statistically significant relationships with functional imaging characteristics in vivo. Regional heterogeneities in glucose uptake were well matched with functional magnetic resonance imaging CBV maps. Our findings support the concept that there is an association of microvascular density and tumor energy metabolism in most human gliomas. In addition, the findings are likely to have important clinical applications in the initial evaluation, treatment, and longitudinal monitoring of patients with malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873068

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  62 in total

1.  Investigating tumor perfusion and metabolism using multiple hyperpolarized (13)C compounds: HP001, pyruvate and urea.

Authors:  Cornelius von Morze; Peder E Z Larson; Simon Hu; Hikari A I Yoshihara; Robert A Bok; Andrei Goga; Jan Henrik Ardenkjaer-Larsen; Daniel B Vigneron
Journal:  Magn Reson Imaging       Date:  2011-12-12       Impact factor: 2.546

2.  Adult human neurogenesis: from microscopy to magnetic resonance imaging.

Authors:  Amanda Sierra; Juan M Encinas; Mirjana Maletic-Savatic
Journal:  Front Neurosci       Date:  2011-04-04       Impact factor: 4.677

3.  An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus.

Authors:  Ana C Pereira; Dan E Huddleston; Adam M Brickman; Alexander A Sosunov; Rene Hen; Guy M McKhann; Richard Sloan; Fred H Gage; Truman R Brown; Scott A Small
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-20       Impact factor: 11.205

4.  Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy.

Authors:  D Gandhi; D B Chepeha; T Miller; R C Carlos; C R Bradford; R Karamchandani; F Worden; A Eisbruch; T N Teknos; G T Wolf; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

5.  Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.

Authors:  Eric S Paulson; Kathleen M Schmainda
Journal:  Radiology       Date:  2008-09-09       Impact factor: 11.105

6.  Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma.

Authors:  Kathleen M Schmainda; Melissa Prah; Jennifer Connelly; Scott D Rand; Raymond G Hoffman; Wade Mueller; Mark G Malkin
Journal:  Neuro Oncol       Date:  2014-01-15       Impact factor: 12.300

7.  Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.

Authors:  Vaios Hatzoglou; Jung Hun Oh; Olivia Buck; Xuling Lin; Michelle Lee; Amita Shukla-Dave; Robert J Young; Kyung K Peck; Behroze Vachha; Andrei I Holodny; Christian Grommes
Journal:  J Neurooncol       Date:  2018-08-02       Impact factor: 4.130

8.  Enhancing fraction in glioma and its relationship to the tumoral vascular microenvironment: A dynamic contrast-enhanced MR imaging study.

Authors:  S J Mills; C Soh; J P B O'Connor; C J Rose; G Buonaccorsi; S Cheung; S Zhao; G J M Parker; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-17       Impact factor: 3.825

9.  Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo.

Authors:  Vassiliki Kostourou; Helen Troy; Joanne F Murray; Elizabeth R Cullis; Guy St J Whitley; John R Griffiths; Simon P Robinson
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

10.  Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.

Authors:  Nicolas Spaeth; Matthias T Wyss; Jens Pahnke; Gregoire Biollaz; Amelie Lutz; Kerstin Goepfert; Gerrit Westera; Valerie Treyer; Bruno Weber; Alfred Buck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-15       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.